✦ LIBER ✦

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Scribed by Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaiser, Peter K.; Chung, Carol Y.; Kim, Robert Y.

Book ID: 117993546
Publisher: Massachusetts Medical Society
Year: 2006
Tongue: English
Weight: 299 KB
Volume: 355
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmoa054481

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab for Neovascular Age-Related

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha

Retinal blood flow in response to an int

Retinal blood flow in response to an intravitreal injection of ranibizumab for neovascular age-related macular degeneration

✍ Jonathan A. Micieli; Edmund Tsui; Wai-Ching Lam; Michael H. Brent; Robert G. Dev 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 282 KB

One-year results of intravitreal ranibiz

One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups

✍ Seungbum Kang; Young-Jung Roh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB

Randomized, Double-Masked, Sham-Controll

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

✍ Carl D. Regillo; David M. Brown; Prema Abraham; Huibin Yue; Tsontcho Ianchulev; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 856 KB

Characteristics of eyes with secondary l

Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration

✍ Alessandro Mariani; Angeliki Deli; Aude Ambresin; Irmela Mantel 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 291 KB

Ranibizumab and Bevacizumab for Neovascu

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 679 KB